- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Undervalued Small Caps
U.S. Pharmaceuticals & Biotech Undervalued Small Caps
Results
3
0 new
Undervalued Small Caps
3 companies
Harmony Biosciences Holdings
Market Cap: US$2.0b
A commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States.
HRMY
US$34.05
7D
12.3%
1Y
13.0%
Aurinia Pharmaceuticals
Market Cap: US$1.1b
A biopharmaceutical company that engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs.
AUPH
US$8.00
7D
-2.6%
1Y
59.4%
MiMedx Group
Market Cap: US$1.1b
Develops and distributes placental tissue allografts for various sectors of healthcare.
MDXG
US$7.05
7D
11.6%
1Y
-5.4%